Biopure Corporation (Nasdaq: BPUR) declared that the results from its Phase II thrombosis revascularization effort hit been publicised in the peer-reviewed EuroIntervention Journal. The essay is entitled “Proof-of-concept effort to appraise haemoprotein supported gas therapeutics in nonappointive percutaneous thrombosis revascularization. Rationale, prescript design, and haemodynamic results.” The autograph was authored by capital policeman Apostle W.

Tags: Led, vascular